PYC Therapeutics (ASX:PYC) Price-to-Operating-Cash-Flow : (As of Jun. 02, 2024)

View and export this data going back to 2005. Start your Free Trial

What is PYC Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-02), PYC Therapeutics's share price is A$0.105. PYC Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01. Hence, PYC Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for PYC Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:PYC's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.775
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

PYC Therapeutics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -58.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -30.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -9.20% per year.

During the past 13 years, PYC Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 34.10% per year. The lowest was -58.70% per year. And the median was 15.70% per year.

PYC Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for PYC Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PYC Therapeutics Price-to-Operating-Cash-Flow Chart

PYC Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

PYC Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PYC Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, PYC Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PYC Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PYC Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PYC Therapeutics's Price-to-Operating-Cash-Flow falls into.

PYC Therapeutics Price-to-Operating-Cash-Flow Calculation

PYC Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.105	/	-0.006
	=

PYC Therapeutics's Share Price of today is A$0.105.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PYC Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

PYC Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PYC Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

PYC Therapeutics (ASX:PYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (ASX:PYC) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009

Website

https://www.pyctx.com

PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.

PYC Therapeutics (ASX:PYC) Headlines

No Headlines